Q3: HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN AFRICAN AMERICAN MEN WITH PROSTATE CANCER: DATA FROM CaPSURE

Lubeck, DP; Grossfeld, Gary D.; Ray, Paul S.; Flanders, SC; Carroll, PR

doi:10.1016/s1098-3015(11)70332-1

Cited by 2 publications

(3 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In our series, the UCLA Prostate Cancer Index and SF-36 scores were comparable or better than patients evaluated by others with the same instruments after radical prostatectomy, external beam radiation, or watchful waiting. 3,4,7,10 While satisfaction in our patients was higher in all areas (physical function, role function, bodily pain, health perception, emotional well-being, social function and energya fatigue) when compared to these studies, acrossstudy comparisons are not valid given the differences in population characteristics.…”

Section: Discussioncontrasting

confidence: 60%

“…The UCLA Prostate Cancer Index has been shown to be reliable and valid in men with and without prostate cancer. 3,7 Patients were also mailed the RAND 36-Item Health Survey 1.0 (SF-36) to quantify general health related quality of life on eight scales including physical function, role limitations due to physical problems, bodily pain, general health perceptions, emotional well-being, role limitations due to emotional problems, social function and fatigue. The SF-36 has been shown to be reliable and valid in various populations.…”

Section: Methodsmentioning

confidence: 99%

See 1 more Smart Citation

Erectile function and quality of life after interstitial radiation therapy for prostate cancer

Sánchez-Ortiz

Broderick

et al. 2000

Int J Impot Res

View full text Add to dashboard Cite

Few studies have evaluated erectile function after interstitial radiation therapy for localized prostate cancer. Using a validated quality of life questionnaire, we assessed post-treatment erectile function and its relationship to treatment satisfaction and quality of life. We retrospectively reviewed the records of 171 consecutive patients who underwent Pd-103 or I-125 brachytherapy for prostate cancer between December 1992 and June 1998. Seventy percent of patients received neoadjuvant androgen deprivation therapy. All patients were mailed a validated questionnaire assessing sexual function and overall quality of life (UCLA Prostate Cancer Index and SF-36). Sixty-seven percent of all questionnaires were available for evaluation (114a171). The mean age was 69.1 y with a mean follow-up of 23 months (range 4 ± 72, median 24). Seventy-one percent of patients (81a114) had pre-treatment erections suf®cient for sustained vaginal penetration. Of these patients, potency was maintained in 49% of men (40a81). An additional 26% had erections ®rm enough for foreplay but not penetration (21a81). Erectile dysfunction rates were signi®cantly lower in younger patients (48%) vs older patients (55%). There was no difference in post-treatment potency between men who received neoadjuvant hormonal therapy and those who did not (P b 0.05). In addition, there were no differences in physical function (86, scale 0 ± 100), general health perception (78), emotional well-being (83), energyafatigue (74), and overall satisfaction (84) between men with erectile dysfunction and those without.In summary, two years following brachytherapy 25% of patients complained of complete (20a81) or partial (26%, 21a81) erectile dysfunction, for an overall rate of 51% (41a81). Short-term neoadjuvant hormonal therapy (`3 ± 6 months) did not increase the likelihood of post-treatment erectile dysfunction. Interestingly, overall satisfaction rates among brachytherapy patients were high (84a100) and surprisingly did not correlate with post-treatment sexual function.

show abstract

Section: Discussioncontrasting

confidence: 60%

Section: Methodsmentioning

confidence: 99%

Erectile function and quality of life after interstitial radiation therapy for prostate cancer

Sánchez-Ortiz

Broderick

et al. 2000

Int J Impot Res

View full text Add to dashboard Cite

show abstract

“…African American participation rates in cancer clinical trials (5%–10%) are comparable to that of Hispanics (5%), higher than that of Asians (2%), and far below that of Caucasian participants, which is typically 80% or higher 11, 12. This is particularly troubling in light of the well‐documented prostate cancer disparities between African American and Caucasian men, including a 60% higher incidence rate, slower recovery from treatment, lower QOL related to physical and psychological symptoms (e.g., increased pain, lower self‐esteem), and a mortality rate that is more than twice of that of Caucasian men 1, 13–16…”

mentioning

confidence: 99%

Facilitating research participation and improving quality of life for African American prostate cancer survivors and their intimate partners

Campbell

Keefe

Scipio

et al. 2007

Cancer

151

274

View full text Add to dashboard Cite

African American men experience worse prostate cancer outcomes compared with those of Caucasian men, not only in incidence and mortality rates, but also in coping with the side effects of treatment. Unfortunately, African American men have been significantly under-represented in research evaluating the efficacy of psychosocial interventions for improving coping in prostate cancer survivors.This pilot study explored the feasibility and efficacy of coping skills training (CST), an intervention developed to enhance coping with treatment side effects in a sample of African American prostate cancer survivors and their intimate partners. The intervention was delivered in a telephone-based format designed to facilitate research participation. A total of 40 couples were randomized to either 6 sessions of CST or usual care. Survivors completed measures of disease-specific quality of life (QOL) related to urinary, sexual, bowel, and hormonal symptom domains, as well as measures of global QOL (i.e., physical functioning and mental health). Partners completed measures of caregiver strain, mood, and vigor.Analysis of data from 30 couples (12 couples in CST, 18 couples in usual care) indicated that CST produced moderate to large treatment effects for QOL related to bowel, urinary, sexual, and hormonal symptoms. Partners who underwent CST reported less caregiver strain, depression, and fatigue, and more vigor, with moderate effect sizes observed that approached conventional levels of statistical significance. These preliminary findings suggest that telephonebased CST is a feasible approach that can successfully enhance coping in African American prostate cancer survivors and their intimate partners.

show abstract

Q3: HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN AFRICAN AMERICAN MEN WITH PROSTATE CANCER: DATA FROM CaPSURE

Cited by 2 publications

References 0 publications

Erectile function and quality of life after interstitial radiation therapy for prostate cancer

Erectile function and quality of life after interstitial radiation therapy for prostate cancer

Facilitating research participation and improving quality of life for African American prostate cancer survivors and their intimate partners

Contact Info

Product

Resources

About